Free Trial
LON:DXRX

Diaceutics (DXRX) Share Price, News & Analysis

Diaceutics logo
GBX 122
+2.00 (+1.67%)
(As of 12:31 PM ET)

About Diaceutics Stock (LON:DXRX)

Key Stats

Today's Range
120.50
122.14
50-Day Range
118
135
52-Week Range
82.50
136
Volume
34,041 shs
Average Volume
110,165 shs
Market Capitalization
£103.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 160
Consensus Rating
Buy

Company Overview

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics. The company also provides DXRX lab education, a suite of tailored and targeted training sessions designed to provide essential education for labs to enable and drive quality testing and biomarker knowledge; DXRX advisory boards that create and enable a valuable interface for pharmaceutical companies with a view to exploring and revealing new insights pertinent to the commercialisation and development of a therapy or companion diagnostic; and DXRX Lab Alerts, an advanced laboratory targeting service delivering tailored, short-form, quick read, educational messages with call-to-action to labs in the DXRX network. In addition, it offers implementation and consulting services for precision medicine diagnostics. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Receive DXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter.

DXRX Stock News Headlines

The centerpiece of Trump’s crypto’s masterplan …
Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”
See More Headlines

DXRX Stock Analysis - Frequently Asked Questions

Diaceutics' stock was trading at GBX 87 on January 1st, 2024. Since then, DXRX stock has increased by 40.2% and is now trading at GBX 122.
View the best growth stocks for 2024 here
.

Shares of DXRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diaceutics investors own include 4D pharma (DDDD), Rolls-Royce Holdings plc (RR.L), Abcam (ABC), B&M European Value Retail (BME), BP (BP), Coats Group (COA) and genedrive (GDR).

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Phone
N/A
Fax
N/A
Employees
151
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 160
High Stock Price Target
GBX 160
Low Stock Price Target
GBX 160
Potential Upside/Downside
+31.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
£-2,850,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£26.09 million
Cash Flow
GBX 39.11 per share
Book Value
GBX 46 per share

Miscellaneous

Free Float
N/A
Market Cap
£103.05 million
Optionable
Not Optionable
Beta
0.58
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:DXRX) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners